Jason Van Pelt
🏛️ Revolving DoorFormer Government Positions:
Legislative Director, Senior LA, LA, Staff Asst: Cong. Ed Whitfield
Legislative Director, Senior Legislative Asst, Legislative Asst, Staff Asst: Rep. Ed Whitfield
🤖
AI Overview
Jason Van Pelt has appeared in 2,153 federal lobbying filings at Crossroads Strategies, LLC, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 41 policy areas.
2,153
Total Filings
1
Firms
50
Clients
41
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 331 | 30 |
| 2019 | 257 | 28 |
| 2020 | 307 | 33 |
| 2021 | 270 | 30 |
| 2022 | 279 | 28 |
| 2023 | 247 | 28 |
| 2024 | 208 | 25 |
| 2025 | 254 | 30 |
Firms
Crossroads Strategies, LLC2153 filings
Top Clients
Takeda Pharmaceuticals America, INC.176 filings
Merck & Co., INC.174 filings
Bristol-myers Squibb163 filings
Sanofi US Services INC.143 filings
Genentech, INC.103 filings
Morgan Stanley & Co LLC88 filings
Eisai, INC.87 filings
Marsh Mclennan74 filings
Dropbox, INC.66 filings
Koch Government Affairs, LLC50 filings
Altria Client Services LLC41 filings
Google Client Services LLC40 filings
Liberty Mutual Group INC.36 filings
Alkermes, INC.35 filings
Vertex Pharmaceuticals Incorporated34 filings
Transamerica Companies31 filings
Spider Strategies, INC.27 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Follow the Money
Tracking lobbying dollars through the financial system.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.